Many of your patients are already receiving excellent care and are still struggling. Hot flashes persist despite treatment, or hormone therapy is contraindicated or declined. Sleep stays fragmented. Irritability and the emotional weight of this transition surface in visits that weren’t scheduled to address them.
A standard visit leaves time to evaluate, prescribe, and adjust treatment. It rarely leaves time for repeated, structured, non-drug intervention. Clinical hypnosis fills that gap: dedicated 50-minute sessions that work alongside your treatment plan.
Published evidence
Clinical hypnosis is among the best-studied non-hormone interventions for vasomotor symptoms, supported by randomized trials and current guidance.
Guideline recognition
The Menopause Society’s 2023 nonhormone therapy position statement recommends clinical hypnosis, alongside cognitive behavioral therapy, for vasomotor symptoms. The 2026 ACOG clinical practice guideline also suggests clinical hypnosis, while noting that the quality of the evidence is limited. [1, 2]
Postmenopausal women, clinician-delivered hypnosis
NIH-funded randomized trial of 187 postmenopausal women with at least seven hot flashes a day. Five weekly sessions of clinical hypnosis versus a structured-attention control. At 12 weeks: 74% reduction in hot flash frequency and 80% in hot flash scores with hypnosis, versus 17% and 15% with control, with improved sleep quality and less interference with daily activities. [3]
Breast cancer survivors
Randomized trial of 60 breast cancer survivors with frequent hot flashes. Five weekly hypnosis sessions reduced hot flash scores by 68% from baseline, with significant improvements over control in anxiety, depression, sleep, and interference. [4]
Self-administered hypnosis versus sham
Randomized, sham-controlled trial of 250 women: six weeks of daily 20-minute hypnosis recordings versus a white-noise “hypnosis” control. Hot flashes fell 53% with hypnosis versus 41% with sham at six weeks, and about 61% versus 44% at the 12-week follow-up; 60% of the hypnosis group, versus 42% with sham, had at least a 50% reduction in hot flash scores. Women with a history of breast cancer showed the largest effect. Adverse events were mild and infrequent. [5]
Interpretation. The evidence is strongest for vasomotor symptoms and the related sleep disruption and interference. The sham-controlled trial shows a meaningful expectancy effect, and a significant effect of hypnosis beyond it at six weeks (P = .04); the analysis of change across the full 12 weeks did not reach significance. In my practice, sessions are paired with self-hypnosis that patients practice at home, consistent with both research models.
Proposed mechanism
Vasomotor symptoms are associated with a narrowed thermoneutral zone, in which small changes in core temperature trigger heat-dissipation responses. How hypnosis reduces hot flashes isn’t fully established. Proposed pathways include reduced sympathetic arousal and a changed perception of, and response to, hot flash onset, including through suggestions of coolness. I don’t overstate these mechanisms, to you or to patients.
Appropriate candidates
Clinical hypnosis may be appropriate, as an adjunct or as a primary non-hormone option, for patients with:
- persistent vasomotor symptoms despite hormone or non-hormone pharmacotherapy
- contraindications to systemic hormone therapy, including a history of estrogen-receptor-positive breast cancer or thromboembolic disease
- a preference for non-drug management, or prior intolerance of medication
- sleep disruption from night sweats and nocturnal awakenings
- irritability, stress, or adjustment difficulties tied to this transition and to midlife role changes
Not a substitute for evaluation or psychiatric care. Patients with undiagnosed abnormal bleeding or other unevaluated symptoms should complete their workup first. Severe depression, suicidality, psychosis, or other acute psychiatric conditions go to psychiatric or emergency care.
Safety and scope
I understand the hesitation many clinicians feel about recommending a hypnotist. Too often, practitioners in this field position themselves against conventional medicine. I don’t. I trained as a physician, and I work as an adjunct to your care, never as an alternative to it.
- Your treatment plan remains yours. I don’t diagnose, and I don’t prescribe, adjust, or recommend stopping hormone therapy, SSRIs or SNRIs, gabapentin, fezolinetant, or any other treatment. Patients are told to discuss any change with their prescriber.
- New, severe, or unusual symptoms come back to you, or go to emergency care: abnormal bleeding, chest pain, significant mood changes.
- Low risk. Non-invasive, no drug interactions, compatible with hormone and non-hormone pharmacotherapy. Patients remain aware and in control throughout.
- No administrative burden. No order, prior authorization, or documentation. Patients book directly and pay privately; I don’t bill insurance.
Your patient remains your patient. When she sleeps better, feels steadier, and copes better with this transition, that improvement reflects on the care you provide.
Practice model
- $150 per 50-minute session, booked and paid individually. No packages.
- The first session is a working session that includes hypnosis when appropriate; I recommend a follow-up within 72 hours to review the response.
- A focused course. The research protocols used about five weekly sessions, or six weeks of daily home practice. I pair sessions with self-hypnosis at home, and we stop when further sessions are no longer useful.
- Where: my Doral office or Google Meet, in English, Spanish, or Portuguese.
- Updates for you: with your patient’s written permission, a brief note that she started and how she is responding.
How to recommend
- Share the patient page: drflavio.com/menopause-midlife. It’s written for your patients: warm, clear, free of exaggerated claims, and explicit that they shouldn’t change any treatment without speaking with you.
- Show the QR code on this page, or print referral cards for your front desk.
- Talk to me directly about a specific patient or candidate.
Let’s meet. It costs you nothing.
Before you refer anyone, I’d like you to know exactly who you’re sending your patients to. I offer referring professionals a short meeting at no cost, by phone, on Google Meet, or in person in South Florida when it works for both of us. You’ll see how I work, we can talk through the kind of patients you have in mind, and you’ll know whether a referral makes sense. It isn’t therapy, and it isn’t a sales pitch.
Or call or text (305) 505-3279, or email flavio@innermasteryworks.com.
About me
- MD, and a PhD in biomedical engineering; MS and BS in engineering
- Clinical hypnosis practice since 1996, with more than 44,000 sessions
- Author of twelve books and a frequent conference presenter
- Has trained and certified more than 3,000 hypnotherapists
References
- The Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573–590.
- American College of Obstetricians and Gynecologists. Clinical Practice Guideline: Management of menopause-related vasomotor, sleep, and mood symptoms. Obstet Gynecol. 2026;148(5):e345–e369.
- Elkins GR, Fisher WI, Johnson AK, Carpenter JS, Keith TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause. 2013;20(3):291–298.
- Elkins G, Marcus J, Stearns V, et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol. 2008;26(31):5022–5026. PubMed.
- Elkins G, Arring N, Morgan G, et al. Self-administered hypnosis vs sham hypnosis for hot flashes: a randomized clinical trial. JAMA Netw Open. 2025;8(11):e2542537. PubMed.
Clinical hypnosis is an adjunct to, not a substitute for, medical care. I don’t diagnose medical conditions or prescribe, adjust, or discontinue medication. Individual results vary, and no particular outcome is guaranteed.